Author

Ana C. Montagud

Observed names: A.C. Montagud, Ana C Montagud

Institutions: Hospital Quirón Torrevieja, IDCQ Hospitales y Sanidad, S.L.U.

Observed institutions: Hospital Universitario Fundación Jiménez Díaz, Hospital Quirón Torrevieja, IDCQ Hospitales y Sanidad, S.L.U.

ORCID: 0000-0002-0647-0551

Observed ORCID: 0000-0002-0647-0551

OpenAlex ID: A5002837733

Seroprevalence Study and Cross-Sectional Survey on COVID-19 for a Plan to Reopen the University of Alicante (Spain)

2021 · Jose Tuells, Cecilia M. Egoavil, et al. · International Journal of Environmental Research and Public Health · 26

Detection of Neutralizing Antibodies against SARS-CoV-2 Post-Vaccination in Health Care Workers of a Large Tertiary Hospital in Spain by Using a Rapid Test LFIC and sVNT-ELISA

2022 · José Tuells, Mónica Parra-Grande, et al. · Vaccines · 12

Prevalencia de anticuerpos neutralizantes frente al SARS-CoV-2 inducidos tras 2 dosis de vacuna BNT162b2 (Pfizer–BioNTech) en trabajadores sanitarios

2024 · A.C. Montagud, J. Llenas-García, et al. · Revista Clínica Española · 7

[COVID-19 vaccination at the University of Alicante (Spain): detection of neutralizing antibodies against SARS-CoV-2 by rapid serological test, a cross-sectional study].

2023 · Ana C Montagud, Nancy Vicente-Alcalde, et al. · PubMed Central · 6

Prevalence of neutralizing antibodies against SARS-CoV-2 using a rapid serological test in health workers of a Spanish Department of Health in Alicante (Spain) before the booster dose of the vaccine

2024 · A.C. Montagud, J. Llenas-García, et al. · Revista Clínica Española (English Edition) · 1

Assessment of SARS-CoV-2 neutralizing antibody persistence using LFIC: a prevalence study after booster doses

2025 · Ana C. Montagud, Raúl Moragues, et al. · BMC Public Health

Seroprevalence against SARS-CoV-2 after booster vaccination in a prison in Alicante (Spain)

2025 · Ana C. Montagud, Raul Moragues, et al. · Frontiers in Public Health

Respuesta a la carta al Director sobre «Prevalencia de anticuerpos neutralizantes frente al SARS-CoV-2 inducidos tras 2 dosis de vacuna BNT162b2 (Pfizer–BioNTech) en trabajadores sanitarios»

2024 · A.C. Montagud, J. Llenas-García, et al. · Revista Clínica Española

Counter reply in reference to “Prevalence of neutralizing antibodies against SARS-CoV-2 using a rapid serological test in health workers of a Spanish Department of Health in Alicante (Spain) before the booster dose of the vaccine”

2024 · A.C. Montagud, J. Llenas-García, et al. · Revista Clínica Española (English Edition)

Works count: 9

Citation count: 52

H-index: 4

I10-index: 2